A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma

(2012) Eric Bouffet et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group

(2012) Joann L. Ater et al.   JOURNAL OF CLINICAL ONCOLOGY

Resistance and Escape From Antiangiogenesis Therapy: Clinical Implications and Future Strategies

(2012) Justin N. Bottsford-Miller et al.   JOURNAL OF CLINICAL ONCOLOGY

Combinatorial drug therapy for cancer in the post-genomic era

(2012) Bissan Al-Lazikani et al.   NATURE BIOTECHNOLOGY

Metronomic Chemotherapy with the COMBAT Regimen in Advanced Pediatric Malignancies: A Multicenter Experience

(2012) D. Zapletalova et al.   ONCOLOGY

Reappraising antiangiogenic therapy for breast cancer

(2011) Robert S. Kerbel   BREAST

Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors

(2011) Andreas Peyrl et al.   PEDIATRIC BLOOD & CANCER

Children Treated With Metronomic Chemotherapy in a Low-income Country

(2010) Traore Fousseyni et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Metronomic chemotherapy: new rationale for new directions

(2010) Eddy Pasquier et al.   Nature Reviews Clinical Oncology

Therapy-Related Acute Myeloid Leukemia With t(8;21) (q22;q22) Shares Many Features With De Novo Acute Myeloid Leukemia With t(8;21)(q22;q22) but Does Not Have a Favorable Outcome

(2009) Steven A. Gustafson et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan

(2009) Roger J. Packer et al.   PEDIATRIC BLOOD & CANCER

Metronomic etoposide/cyclophosphamide/celecoxib regimen given to children and adolescents with refractory cancer: A preliminary monocentric study

(2008) Nicolas André et al.   CLINICAL THERAPEUTICS

PPAR  agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition

(2008) D. Panigrahy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA